Aminoacyl transfer RNA synthetase (ARS) is a cytoplasmic protein synthetase that catalyzes the binding of amino acids to their corresponding transfer RNA in an energy-dependent manner. Eight autoantibodies reacting with different ARSs have been recognized: anti-Jo-1 (histidyl), anti-PL-7 (threonyl), anti-PL-12 (alanyl), anti-EJ (glycyl), anti-OJ (isoleucyl), anti-KS (asparaginyl), anti-Zo (phenylalanyl), and anti-Ha (tyrosyl). Antisynthetase syndrome, characterized by myositis, interstitial lung disease, skin rash, arthropathy, and Raynaud phenomenon, is a clinical entity based on the presence of 1 of the ARS antibodies in patient’s serum.
1 Because anti-Jo-1 antibodies are preferentially screened in patients with myositis, to our knowledge, muscle involvement of antisynthetase syndrome has not been fully elucidated.